Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Pancreatic cancer registry launches to map Real-World treatment outcomes

NCT ID NCT05526443

Knowledge-focused Sponsor: Medical University of Graz Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Sep 02, 2026 · Updated 3 times

Summary

This registry is collecting information from 1,500 people with advanced pancreatic cancer in Austria to see how different chemotherapy treatments work in everyday practice. Researchers will track which treatments are used, how well they work, and what side effects occur. The goal is to better understand real-world outcomes and identify factors that predict success.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 1,500 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2023

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

1500 adult patients with locally advanced inoperable and/or metastasized PDAC undergoing first line therapy with a platinum- or gemcitabin- based chemotherapy

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 18 years, female and male * ECOG (Eastern Cooperative Oncology Group) Scale 0-2 * Diagnosis of histologically confirmed locally advanced inoperable and/or metastatic PDAC * Patients undergoing palliative 1st line therapy with a platinum- or gemcitabine- based chemotherapy in case of previous (neo)adjuvant therapy also patients who receive nal-Irinotecan/5-FU/Leukovorin as palliative first line are eglible * Signed informed consent for prospective patients, for retrospective cases no informed consent is required Exclusion Criteria: * Patients with locally advanced operable PDAC who do not receive palliative chemotherapy * Patients with locally advanced borderline resectable PDAC who do not receive palliative chemotherapy

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Advanced pancreatic carcinoma are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

exocrine pancreatic carcinoma malignant pancreatic neoplasm pancreatic adenocarcinoma pancreatic ductal adenocarcinoma pancreatic neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Advanced pancreatic carcinoma Pancreatic cancer

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    14 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Barmherzige Schwestern Krankenhaus Wien

    RECRUITING

    Vienna, 1060, Austria

  • Kepler University Hospital

    RECRUITING

    Linz, 4020, Austria

  • Krankenhaus St. Vinzenz Zams

    RECRUITING

    Zams, 6511, Austria

  • Krankenhaus der Barmherzigen Brüder

    RECRUITING

    Graz, 8020, Austria

  • Landesklinikum Amstetten

    RECRUITING

    Amstetten, 3300, Austria

  • Landesklinikum Feldkirch

    RECRUITING

    Feldkirch, 6800, Austria

  • Landesklinikum Klagenfurt

    RECRUITING

    Klagenfurt, 9020, Austria

  • Medical University Graz Department of Oncology

    RECRUITING

    Graz, Styria, 8036, Austria

  • Ordensklinikum Linz

    RECRUITING

    Linz, Upper Austria, 4010, Austria

  • Pancreatic Cancer Unit des Comprehensive Cancer Center (CCC-PCU)

    RECRUITING

    Vienna, 1090, Austria

  • Salzburg State Hospital, PMU University Clinic

    RECRUITING

    Salzburg, 5020, Austria

  • St. Josef Krankenhaus Wien

    RECRUITING

    Vienna, 1130, Austria

  • Universitätsklinikum Innsbruck,

    RECRUITING

    Innsbruck, 6020, Austria

  • Universitätsklinikum St. Pölten

    RECRUITING

    Sankt Pölten, 3100, Austria

More trials for these conditions

Other studies related to the condition(s) this trial covers.